THECLA ASOLUKA: Open Payments
NPI 1306483631 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 3 payments from 3 companies in 2025. Trend: 2023 $44 · 2024 $52 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $110 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| Janssen Pharmaceuticals, Inc | 1 | $62 |
Products named: CAPLYTA, REXULTI, INVEGA SUSTENNA.
Industry payments across MD — which companies pay providers there.
